Aging Hormone Linked to Cancer Deaths

[Guest guest]

Aging Hormone Linked to Cancer Deaths

http://www.ivanhoe.com/channels/p_channelstory.cfm? & storyid=23726

(Ivanhoe Newswire) -- Older men with high levels of the hormone IGF-I

(insulin-like growth factor 1) are at increased risk of cancer death that is

independent of age, lifestyle and cancer history.

IGF-I is a protein hormone similar in structure to insulin and is regulated in

the body by growth hormone (GH). Levels of GH and IGF-I decline progressively

with age in both men and women, and this drop is thought to be related to

deteriorating health conditions found with advancing age. In an attempt to

combat aging some people use GH as its actions elevate IGF-1.The current study,

however, showed that older men who had higher IGF-I levels were more likely to

die from a cancer-related cause in the ensuing 18 years than men with lower

levels.

" This is the first population-based study to show an association of higher IGF-I

levels with increased risk of a cancer-related death in older men, "

corresponding author Gail Laughlin, Ph.D., of the University of California San

Diego, was quoted as saying. " Although the design of this study does not

explicitly show that the higher IGF-I levels caused the cancer death, it does

encourage more study as well as a reexamination of the use of IGF-I enhancing

therapies as an anti-aging strategy. "

Researchers used data on 633 men aged 50 and older from the Rancho Bernardo

Study, a population-based study of healthy aging. Study participants took part

in a research clinic examination between the 1988 and 1991, when their blood was

analyzed and IGF-I was measured. Participants were followed through July 2006.

Researchers found men who had IGF-I levels above 100 ng/ml had almost twice the

risk of cancer death in the following 18 years as men with lower levels.

" In this study, the increased risk of cancer death for older men with high

levels of IGF-I was not explained by differences in age, body size, lifestyle or

cancer history, " lead author Major, Ph.D., at the National Cancer

Institute, was quoted as saying. " If these results are confirmed in other

populations, these findings suggest that serum IGF-I may have potential

importance as a biomarker for prognostic testing. "

SOURCE: Journal of Clinical Endocrinology & Metabolism (JCEM), March 1, 2010

[Guest guest]

Yep I seen this and others like it about older men taking GH to beat aging. For

every study you find saying this there are as many staying the opposite.

In my case I am very low on GH and told by my Heart Dr. this is not good for the

heart. I have been told about my low GH levels and that I need to treat it. I

read about it stuff like this and decided not to go on HGH. Well guess what I

had to have heart bypass sugary a yr ago and still have not recovered 100% from

it. I should have listened to my Dr. and went on GH.

Co-Moderator

Phil

> From: ihor n <ihor43us@...>

> Subject: Aging Hormone Linked to Cancer Deaths

>

> Date: Thursday, March 4, 2010, 9:39 AM

> Aging Hormone Linked to Cancer

> Deaths

>

> http://www.ivanhoe.com/channels/p_channelstory.cfm? & storyid=23726

>

> (Ivanhoe Newswire) -- Older men with high levels of the

> hormone IGF-I (insulin-like growth factor 1) are at

> increased risk of cancer death that is independent of age,

> lifestyle and cancer history.

>

> IGF-I is a protein hormone similar in structure to insulin

> and is regulated in the body by growth hormone (GH). Levels

> of GH and IGF-I decline progressively with age in both men

> and women, and this drop is thought to be related to

> deteriorating health conditions found with advancing age. In

> an attempt to combat aging some people use GH as its actions

> elevate IGF-1.The current study, however, showed that older

> men who had higher IGF-I levels were more likely to die from

> a cancer-related cause in the ensuing 18 years than men with

> lower levels.

>

> " This is the first population-based study to show an

> association of higher IGF-I levels with increased risk of a

> cancer-related death in older men, " corresponding author

> Gail Laughlin, Ph.D., of the University of California San

> Diego, was quoted as saying. " Although the design of this

> study does not explicitly show that the higher IGF-I levels

> caused the cancer death, it does encourage more study as

> well as a reexamination of the use of IGF-I enhancing

> therapies as an anti-aging strategy. "

>

> Researchers used data on 633 men aged 50 and older from the

> Rancho Bernardo Study, a population-based study of healthy

> aging. Study participants took part in a research clinic

> examination between the 1988 and 1991, when their blood was

> analyzed and IGF-I was measured. Participants were followed

> through July 2006. Researchers found men who had IGF-I

> levels above 100 ng/ml had almost twice the risk of cancer

> death in the following 18 years as men with lower levels.

>

> " In this study, the increased risk of cancer death for

> older men with high levels of IGF-I was not explained by

> differences in age, body size, lifestyle or cancer history, "

> lead author Major, Ph.D., at the National Cancer

> Institute, was quoted as saying. " If these results are

> confirmed in other populations, these findings suggest that

> serum IGF-I may have potential importance as a biomarker for

> prognostic testing. "

>

> SOURCE: Journal of Clinical Endocrinology & Metabolism

> (JCEM), March 1, 2010

>

>

>

>

> ------------------------------------

>

>

[Guest guest]

Glad that you are recovering from the surgery Phil, we need you.

I guess the article should have been a bit more specific. I would think that the

danger comes from supplementing HGH to reach a level above the norm, while

supplementing to attain the norm is beneficial.

The same as with Testosterone.

>

> > From: ihor n <ihor43us@...>

> > Subject: Aging Hormone Linked to Cancer Deaths

> >

> > Date: Thursday, March 4, 2010, 9:39 AM

> > Aging Hormone Linked to Cancer

> > Deaths

> >

> > http://www.ivanhoe.com/channels/p_channelstory.cfm? & storyid=23726

> >

> > (Ivanhoe Newswire) -- Older men with high levels of the

> > hormone IGF-I (insulin-like growth factor 1) are at

> > increased risk of cancer death that is independent of age,

> > lifestyle and cancer history.

> >

> > IGF-I is a protein hormone similar in structure to insulin

> > and is regulated in the body by growth hormone (GH). Levels

> > of GH and IGF-I decline progressively with age in both men

> > and women, and this drop is thought to be related to

> > deteriorating health conditions found with advancing age. In

> > an attempt to combat aging some people use GH as its actions

> > elevate IGF-1.The current study, however, showed that older

> > men who had higher IGF-I levels were more likely to die from

> > a cancer-related cause in the ensuing 18 years than men with

> > lower levels.

> >

> > " This is the first population-based study to show an

> > association of higher IGF-I levels with increased risk of a

> > cancer-related death in older men, " corresponding author

> > Gail Laughlin, Ph.D., of the University of California San

> > Diego, was quoted as saying. " Although the design of this

> > study does not explicitly show that the higher IGF-I levels

> > caused the cancer death, it does encourage more study as

> > well as a reexamination of the use of IGF-I enhancing

> > therapies as an anti-aging strategy. "

> >

> > Researchers used data on 633 men aged 50 and older from the

> > Rancho Bernardo Study, a population-based study of healthy

> > aging. Study participants took part in a research clinic

> > examination between the 1988 and 1991, when their blood was

> > analyzed and IGF-I was measured. Participants were followed

> > through July 2006. Researchers found men who had IGF-I

> > levels above 100 ng/ml had almost twice the risk of cancer

> > death in the following 18 years as men with lower levels.

> >

> > " In this study, the increased risk of cancer death for

> > older men with high levels of IGF-I was not explained by

> > differences in age, body size, lifestyle or cancer history, "

> > lead author Major, Ph.D., at the National Cancer

> > Institute, was quoted as saying. " If these results are

> > confirmed in other populations, these findings suggest that

> > serum IGF-I may have potential importance as a biomarker for

> > prognostic testing. "

> >

> > SOURCE: Journal of Clinical Endocrinology & Metabolism

> > (JCEM), March 1, 2010

> >

> >

> >

> >

> > ------------------------------------

> >

> >

[Guest guest]

I can't say I don't worry about being on HGH it is changing a lot of my meds. I

was doing 4 grains of Armour now only doing 15 mgs go figure. I went hyper and

it took 5 weeks to figure this out now one of the guys up on this at Dr. 's

forum says as you get GH levels up you don't need higher levels of T. I also

got some bad HCG Novarel through all of this and it drove up my Estradiol levels

so high I needed to take 1 mg. of Arimidex to keep it down this is nuts. Then I

seen my Arimidex was Exp. 2 yrs my Dr. would give me 30 pills my cost was low on

it so when I refilled it I just pored when new stuff on top of the stuff I had.

When the bottle was full I stopped refiling it. Now the bottle is less the half

full and the Arimidex is old and was not working good.

This was why I needed to take one mgs a day to keep my levels down. I got some

new Arimidex and a new lot of HCG Novarel.

My problem now is this things that went wrong caused me to have Panic Attacks

now every time I think about how I feel I get this dam Panic feeling and can't

tell if it's my meds or my Panic problem. I need a good 2 weeks with out a

Panic problem to get pasted this so it's been a trip.

Co-Moderator

Phil

> From: ihor n <ihor43us@...>

> Subject: Re: Aging Hormone Linked to Cancer Deaths

>

> Date: Saturday, March 6, 2010, 11:45 AM

> Glad that you are recovering from the

> surgery Phil, we need you.

>

> I guess the article should have been a bit more specific. I

> would think that the danger comes from supplementing HGH to

> reach a level above the norm, while supplementing to attain

> the norm is beneficial.

>

> The same as with Testosterone.

>

>

>

>

> >

> > > From: ihor n <ihor43us@...>

> > > Subject: Aging Hormone Linked to

> Cancer Deaths

> > >

> > > Date: Thursday, March 4, 2010, 9:39 AM

> > > Aging Hormone Linked to Cancer

> > > Deaths

> > >

> > >  http://www.ivanhoe.com/channels/p_channelstory.cfm? & storyid=23726

> > > 

> > > (Ivanhoe Newswire) -- Older men with high levels

> of the

> > > hormone IGF-I (insulin-like growth factor 1) are

> at

> > > increased risk of cancer death that is

> independent of age,

> > > lifestyle and cancer history.

> > >

> > > IGF-I is a protein hormone similar in structure

> to insulin

> > > and is regulated in the body by growth hormone

> (GH). Levels

> > > of GH and IGF-I decline progressively with age in

> both men

> > > and women, and this drop is thought to be related

> to

> > > deteriorating health conditions found with

> advancing age. In

> > > an attempt to combat aging some people use GH as

> its actions

> > > elevate IGF-1.The current study, however, showed

> that older

> > > men who had higher IGF-I levels were more likely

> to die from

> > > a cancer-related cause in the ensuing 18 years

> than men with

> > > lower levels.

> > >

> > > " This is the first population-based study to show

> an

> > > association of higher IGF-I levels with increased

> risk of a

> > > cancer-related death in older men, " corresponding

> author

> > > Gail Laughlin, Ph.D., of the University of

> California San

> > > Diego, was quoted as saying. " Although the design

> of this

> > > study does not explicitly show that the higher

> IGF-I levels

> > > caused the cancer death, it does encourage more

> study as

> > > well as a reexamination of the use of IGF-I

> enhancing

> > > therapies as an anti-aging strategy. "

> > >

> > > Researchers used data on 633 men aged 50 and

> older from the

> > > Rancho Bernardo Study, a population-based study

> of healthy

> > > aging. Study participants took part in a research

> clinic

> > > examination between the 1988 and 1991, when their

> blood was

> > > analyzed and IGF-I was measured. Participants

> were followed

> > > through July 2006. Researchers found men who had

> IGF-I

> > > levels above 100 ng/ml had almost twice the risk

> of cancer

> > > death in the following 18 years as men with lower

> levels.

> > >

> > > " In this study, the increased risk of cancer

> death for

> > > older men with high levels of IGF-I was not

> explained by

> > > differences in age, body size, lifestyle or

> cancer history, "

> > > lead author Major, Ph.D., at the

> National Cancer

> > > Institute, was quoted as saying. " If these

> results are

> > > confirmed in other populations, these findings

> suggest that

> > > serum IGF-I may have potential importance as a

> biomarker for

> > > prognostic testing. "

> > >

> > > SOURCE: Journal of Clinical Endocrinology &

> Metabolism

> > > (JCEM), March 1, 2010

> > >

> > >

> > >

> > >

> > > ------------------------------------

> > >

> > >

[Guest guest]

I suffer from anxiety and panic attacks so I know how you feel. You were on the

equivalent of 400 synthroid? I thought my dose was high, 250! feel better!

> > >

> > > > From: ihor n <ihor43us@>

> > > > Subject: Aging Hormone Linked to

> > Cancer Deaths

> > > >

> > > > Date: Thursday, March 4, 2010, 9:39 AM

> > > > Aging Hormone Linked to Cancer

> > > > Deaths

> > > >

> > > >  http://www.ivanhoe.com/channels/p_channelstory.cfm? & storyid=23726

> > > > 

> > > > (Ivanhoe Newswire) -- Older men with high levels

> > of the

> > > > hormone IGF-I (insulin-like growth factor 1) are

> > at

> > > > increased risk of cancer death that is

> > independent of age,

> > > > lifestyle and cancer history.

> > > >

> > > > IGF-I is a protein hormone similar in structure

> > to insulin

> > > > and is regulated in the body by growth hormone

> > (GH). Levels

> > > > of GH and IGF-I decline progressively with age in

> > both men

> > > > and women, and this drop is thought to be related

> > to

> > > > deteriorating health conditions found with

> > advancing age. In

> > > > an attempt to combat aging some people use GH as

> > its actions

> > > > elevate IGF-1.The current study, however, showed

> > that older

> > > > men who had higher IGF-I levels were more likely

> > to die from

> > > > a cancer-related cause in the ensuing 18 years

> > than men with

> > > > lower levels.

> > > >

> > > > " This is the first population-based study to show

> > an

> > > > association of higher IGF-I levels with increased

> > risk of a

> > > > cancer-related death in older men, " corresponding

> > author

> > > > Gail Laughlin, Ph.D., of the University of

> > California San

> > > > Diego, was quoted as saying. " Although the design

> > of this

> > > > study does not explicitly show that the higher

> > IGF-I levels

> > > > caused the cancer death, it does encourage more

> > study as

> > > > well as a reexamination of the use of IGF-I

> > enhancing

> > > > therapies as an anti-aging strategy. "

> > > >

> > > > Researchers used data on 633 men aged 50 and

> > older from the

> > > > Rancho Bernardo Study, a population-based study

> > of healthy

> > > > aging. Study participants took part in a research

> > clinic

> > > > examination between the 1988 and 1991, when their

> > blood was

> > > > analyzed and IGF-I was measured. Participants

> > were followed

> > > > through July 2006. Researchers found men who had

> > IGF-I

> > > > levels above 100 ng/ml had almost twice the risk

> > of cancer

> > > > death in the following 18 years as men with lower

> > levels.

> > > >

> > > > " In this study, the increased risk of cancer

> > death for

> > > > older men with high levels of IGF-I was not

> > explained by

> > > > differences in age, body size, lifestyle or

> > cancer history, "

> > > > lead author Major, Ph.D., at the

> > National Cancer

> > > > Institute, was quoted as saying. " If these

> > results are

> > > > confirmed in other populations, these findings

> > suggest that

> > > > serum IGF-I may have potential importance as a

> > biomarker for

> > > > prognostic testing. "

> > > >

> > > > SOURCE: Journal of Clinical Endocrinology &

> > Metabolism

> > > > (JCEM), March 1, 2010

> > > >

> > > >

> > > >

> > > >

> > > > ------------------------------------

> > > >

> > > >

[Guest guest]

It looks like I don't need to treat my thyroid anymore. I read that this

happens some Dr.'s they people off there meds after about a yr. to see how they

do and a lot find they don't need meds anymore the thyroid must heal.

Co-Moderator

Phil

> From: andrenym007 <no_reply >

> Subject: Re: Aging Hormone Linked to Cancer Deaths

>

> Date: Saturday, March 6, 2010, 1:01 PM

> I suffer from anxiety and panic

> attacks so I know how you feel. You were on the equivalent

> of 400 synthroid? I thought my dose was high, 250! feel

> better!

>

>

> > > >

> > > > > From: ihor n <ihor43us@>

> > > > > Subject: Aging Hormone

> Linked to

> > > Cancer Deaths

> > > > >

> > > > > Date: Thursday, March 4, 2010, 9:39 AM

> > > > > Aging Hormone Linked to Cancer

> > > > > Deaths

> > > > >

> > > > >  http://www.ivanhoe.com/channels/p_channelstory.cfm? & storyid=23726

> > > > > 

> > > > > (Ivanhoe Newswire) -- Older men with

> high levels

> > > of the

> > > > > hormone IGF-I (insulin-like growth

> factor 1) are

> > > at

> > > > > increased risk of cancer death that is

> > > independent of age,

> > > > > lifestyle and cancer history.

> > > > >

> > > > > IGF-I is a protein hormone similar in

> structure

> > > to insulin

> > > > > and is regulated in the body by growth

> hormone

> > > (GH). Levels

> > > > > of GH and IGF-I decline progressively

> with age in

> > > both men

> > > > > and women, and this drop is thought to

> be related

> > > to

> > > > > deteriorating health conditions found

> with

> > > advancing age. In

> > > > > an attempt to combat aging some people

> use GH as

> > > its actions

> > > > > elevate IGF-1.The current study,

> however, showed

> > > that older

> > > > > men who had higher IGF-I levels were

> more likely

> > > to die from

> > > > > a cancer-related cause in the ensuing

> 18 years

> > > than men with

> > > > > lower levels.

> > > > >

> > > > > " This is the first population-based

> study to show

> > > an

> > > > > association of higher IGF-I levels with

> increased

> > > risk of a

> > > > > cancer-related death in older men, "

> corresponding

> > > author

> > > > > Gail Laughlin, Ph.D., of the University

> of

> > > California San

> > > > > Diego, was quoted as saying. " Although

> the design

> > > of this

> > > > > study does not explicitly show that the

> higher

> > > IGF-I levels

> > > > > caused the cancer death, it does

> encourage more

> > > study as

> > > > > well as a reexamination of the use of

> IGF-I

> > > enhancing

> > > > > therapies as an anti-aging strategy. "

> > > > >

> > > > > Researchers used data on 633 men aged

> 50 and

> > > older from the

> > > > > Rancho Bernardo Study, a

> population-based study

> > > of healthy

> > > > > aging. Study participants took part in

> a research

> > > clinic

> > > > > examination between the 1988 and 1991,

> when their

> > > blood was

> > > > > analyzed and IGF-I was measured.

> Participants

> > > were followed

> > > > > through July 2006. Researchers found

> men who had

> > > IGF-I

> > > > > levels above 100 ng/ml had almost twice

> the risk

> > > of cancer

> > > > > death in the following 18 years as men

> with lower

> > > levels.

> > > > >

> > > > > " In this study, the increased risk of

> cancer

> > > death for

> > > > > older men with high levels of IGF-I was

> not

> > > explained by

> > > > > differences in age, body size,

> lifestyle or

> > > cancer history, "

> > > > > lead author Major, Ph.D., at

> the

> > > National Cancer

> > > > > Institute, was quoted as saying. " If

> these

> > > results are

> > > > > confirmed in other populations, these

> findings

> > > suggest that

> > > > > serum IGF-I may have potential

> importance as a

> > > biomarker for

> > > > > prognostic testing. "

> > > > >

> > > > > SOURCE: Journal of Clinical

> Endocrinology &

> > > Metabolism

> > > > > (JCEM), March 1, 2010

> > > > >

> > > > >

> > > > >

> > > > >

> > > > > ------------------------------------

> > > > >

> > > > >